Msn Azacitidine For Injection 100 mg (AZADUAL)

Name: Msn Azacitidine For Injection 100 mg (AZADUAL)
Brand: BALAJI CHEMICAL STORES
Price: 2000.0 INR
Availability: InStock

Price 2000.0 INR/ Box

Get a Price/Quote

MOQ : 10 Boxes

Msn Azacitidine For Injection 100 mg (AZADUAL) Specification

Packaging Type
Vial with carton box

Brand Name
Azadual

Pacakaging (Quantity Per Box)
1 vial per box

Dosage Form
Injection

Life Span
Refer to expiry date on pack

Indication
Used in the treatment of myelodysplastic syndromes and certain types of blood cancer

Salt Composition
Azacitidine 100 mg

Origin of Medicine
India

Drug Type
Prescription medicine

Ingredients
Azacitidine

Physical Form
Lyophilized powder

Function

Recommended For
For intravenous or subcutaneous use only

Dosage
100 mg/vial (as prescribed by physician)

Dosage Guidelines
Use as a single-use vial; administer as directed by a healthcare professional

Suitable For
Adults (as prescribed)

Quantity
1 vial

Storage Instructions
Store below 25C, protect from light

Route of Administration
Intravenous or Subcutaneous

Reconstitution
Lyophilized powder requires proper dilution before administration

Prescription Status
Rx Only

Single Use/Multiple Use
Single use only

About Msn Azacitidine For Injection 100 mg (AZADUAL)

Azacitidine for injection is a nucleoside analog used to treat myelodysplastic syndromes and acute myeloid leukemia. It restores normal blood cell production by inhibiting abnormal DNA methylation. Administered subcutaneously or intravenously, it improves survival, delays disease progression, and reduces transfusion dependence.

Powerful Chemotherapy Solution for Blood Disorders

Azadual (Msn Azacitidine For Injection 100 mg) is a reliable therapeutic option formulated specifically to address myelodysplastic syndromes and select blood cancers. Designed as a lyophilized powder, it ensures stability and potency, requiring careful reconstitution before use. With administration routes tailored for either intravenous or subcutaneous injection, Azadual offers versatility under the supervision of medical professionals.

Single-Use Safety and Proper Handling

Each vial of Azadual is intended for single use to maintain safety and efficacy. As a prescription medicine, this product should only be prepared and administered by healthcare providers with experience in chemotherapy. Proper storage below 25C and protection from light are essential for preserving the medication's integrity until use.

FAQ's of Msn Azacitidine For Injection 100 mg (AZADUAL):

Q: How should Azadual (Msn Azacitidine For Injection 100 mg) be administered?

A: Azadual is intended for intravenous or subcutaneous injection only, and must be administered by a qualified healthcare professional who will reconstitute the lyophilized powder and ensure proper dilution prior to use.

Q: What is the main indication for using Azadual?

A: Azadual is prescribed for the treatment of myelodysplastic syndromes and certain types of blood cancer in adult patients, as determined by a physician.

Q: When is Azadual reconstituted and used?

A: The lyophilized powder is reconstituted immediately prior to use, following strict preparation guidelines provided by the healthcare professional to ensure accurate dosing and patient safety.

Q: Where should Azadual be stored before administration?

A: Azadual should be stored below 25C and protected from light. Before reconstitution, keep the vial in its original carton until ready to be used.

Q: What is the process for preparing Azadual for injection?

A: A medical professional will dilute the lyophilized powder as per protocol, ensuring the drug is fully dissolved before administering it via the prescribed route-either intravenously or subcutaneously.

Q: Is Azadual suitable for repeated use from the same vial?

A: No. Each vial of Azadual is for single use only. Any remaining product after the dose is administered must be properly discarded.

Q: What benefit does Azadual provide to patients?

A: Azadual offers significant benefits in managing myelodysplastic syndromes and certain blood cancers by acting as an effective chemotherapeutic agent, potentially improving disease outcomes when used as prescribed.

Tell us about your requirement